BILLERICA, Mass. --(BUSINESS WIRE)--Sep. 5, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will take part in a fireside chat at the Morgan Stanley 21 st Annual

BILLERICA, Mass. --(BUSINESS WIRE)--Aug. 21, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced that it appointed William (Bill) P. Donnelly to its Board of Directors. Mr.

BILLERICA, Mass. --(BUSINESS WIRE)--Aug. 9, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced that it has appointed Vandana Sriram , CPA, as Chief Financial Officer (CFO),

BILLERICA, Mass. --(BUSINESS WIRE)--Aug. 7, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the three months ended June 30, 2023 . Second Quarter Financial Highlights Total revenue

BILLERICA, Mass. --(BUSINESS WIRE)--Aug. 3, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will be presenting at the Canaccord Genuity 43rd Annual Growth

The company’s ultra-sensitive biomarker technology supports milestone achievement in establishing a method for clinicians to identify and interpret elevated values of sNfL in children and adolescents BILLERICA, Mass. --(BUSINESS WIRE)--Jul. 31, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company

BILLERICA, Mass. --(BUSINESS WIRE)--Jul. 20, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will report financial results for the second quarter 2023 before the market opens on Tuesday, August

Test will play an important role in the evaluation of patients experiencing cognitive symptoms consistent with early signs of Alzheimer’s disease BILLERICA, Mass. --(BUSINESS WIRE)--Jul. 6, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough

BILLERICA, Mass. --(BUSINESS WIRE)--Jun. 7, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will speak at the Goldman Sachs Annual Global Healthcare Conference

BILLERICA, Mass. --(BUSINESS WIRE)--May 9, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the three months ended March 31, 2023 . “Our corporate transformation initiated in August